Anti-CEACAM5 / CEA / CD66e Reference Antibody (labetuzumab govitecan), IgG1

Produktübersicht

• Artikelname: Anti-CEACAM5 / CEA / CD66e Reference Antibody (labetuzumab govitecan), IgG1
• Artikelnummer: SYB-CHB262
• Hersteller Artikelnummer: CHB262
• Alternativnummer: SYB-CHB262-100UG,SYB-CHB262-1MG
• Hersteller: Sanyou Bio
• Kategorie: Antikörper
• Applikation: ELISA, FA, FACS, Kinetics
• Spezies Reaktivität: Human
• Alternative Synonym: IMMU-130, hMN-14-SN38

Produktbeschreibung

Labetuzumab Govitecan is an antibody-drug conjugate (ADC) containing labetuzumab, a mildly reduced, anti-CEACAM5 humanized monoclonal antibody, conjugated to the potent topoisomerase I inhibitor SN-38, with antineoplastic activity.

Produkteigenschaften

• Konzentration: 1mg/ml
• Molekulargewicht: 157 kDa
• Isotyp: IgG1
• NCBI: 06731
• Puffer: 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
• Reinheit: >90%
• Formulierung: Lyophilized
• Target-Kategorie: CEACAM5 / CEA / CD66e